GISELLE RIOS: Open Payments
NPI 1043832827 · COCOA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,760 in 96 payments from 17 companies in 2025. Trend: 2023 $1,387 · 2024 $1,401 · 2025 $1,760
Food & beverage: $1,760
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $265 |
| ABBVIE INC. | 14 | $239 |
| Vanda Pharmaceuticals Inc. | 14 | $222 |
| Amgen Inc. | 12 | $164 |
| PFIZER INC. | 13 | $163 |
| Novo Nordisk Inc | 5 | $94 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| Abbott Laboratories | 4 | $81 |
| Lilly USA, LLC | 3 | $66 |
Products named: FANAPT, VRAYLAR, OTEZLA, AIRSUPRA, BREZTRI, NURTEC ODT, GEMTESA, JARDIANCE.
Industry payments across FL — which companies pay providers there.
